Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

ClinicalTrials.gov ID: NCT00005035

Public ClinicalTrials.gov record NCT00005035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Oxaliplatin in Patients With Advanced Carcinoma of the Head and Neck

Study identification

NCT ID
NCT00005035
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ohio State University Comprehensive Cancer Center
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 1999
Primary completion
Not listed
Completion
Feb 29, 2004
Last update posted
Jan 30, 2013

1999 – 2004

United States locations

U.S. sites
11
U.S. states
4
U.S. cities
10
Facility City State ZIP Site status
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Louis A. Weiss Memorial Hospital Chicago Illinois 60640
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526
Evanston Northwestern Health Care Evanston Illinois 60201
Lutheran General Cancer Care Center Park Ridge Illinois 60068
Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois 61602
Central Illinois Hematology Oncology Center Springfield Illinois 62701
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46885-5099
Saint Joseph's Regional Medical Center South Bend Indiana 46634-1935
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
Cancer Centers of the Carolinas Greenville South Carolina 29605

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00005035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00005035 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →